• No results found

Angiogenesis and screening in uveal melanoma Missotten, G.S.

N/A
N/A
Protected

Academic year: 2021

Share "Angiogenesis and screening in uveal melanoma Missotten, G.S."

Copied!
4
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Angiogenesis and screening in uveal melanoma

Missotten, G.S.

Citation

Missotten, G. S. (2005, September 14). Angiogenesis and screening in uveal melanoma. Leiden. Retrieved from

https://hdl.handle.net/1887/3021

Version:

Corrected Publisher’s Version

License:

Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of

Leiden

Downloaded from:

https://hdl.handle.net/1887/3021

(2)

Angiogenesis and

Screening

in uveal melanoma

Proefschrift ter verkrijging van

de graad van D octor aan de U niversiteit Leiden, op gezag van de R ector M agnificus D r. D .D .B reim er,

hoogleraar in de faculteit der W iskunde en N atuurw etenschappen en die der G eneeskunde,

volgens besluit van het C ollege voor Prom oties te verdedigen op w oensdag 14 septem ber 20 0 5

(3)

P R O M OT I ECO M M I S S I E

Promotor: Prof. Dr. J.E.E. Keunen Copromotores: Dr. M .J. Jager

Dr. R.O. Schlingem ann Academisch Medisch Centrum Amsterdam Referent: Prof. Dr. S. Seregard Karolinska Instituut, Stockholm (Zweden) Beoordelingscommisie:

Prof. Dr J-J. de Laey Rijksuniversiteit Gent (België) Dr. R. de Waal Radboud Universiteit Nijmegen Prof. Dr. R. J.W. de Keizer

Financial support by Alcon, Allergan, Lameris Ootech BV, Landelijke Stichting voor Blinden en Slechtzienden, Leids Oogheelkundig Ondersteunings Fonds, Pfizer BV and Tramedico for the publication of this thesis is gratefullly acknowledged.

The layout of this thesis was designed by E. Ruppol.

This thesis was supported by the Dutch Cancer Society (Koningin W ilhelmina Kankerfonds).

ANGIOGENESIS AND SCREENING IN UVEAL MELANOMA

CHAPTER 1 General introduction 9

CHAPTER 2 Long-term follow-up in uveal m elanom a after enucleation 33

Com parison of histopathologic prognostic factors Submitted

CHAPTER 3 Vascular endothelial growth factor-A in eyes with uveal m elanom a 55

Submitted

CHAPTER 4 Expression of angiogenic factors in uveal m elanom a in vitro, 73

in vivo and in patients Submitted

CHAPTER 5 Heat shock protein expression in the eye and in uveal m elanom a 91

Investigative Ophthalmology Visual Science 2003; 44: 3059-3065.

CHAPTER 6 Prognostic value of S-100b serum concentration in patients 109

with uveal m elanom a

Archives Ophthalmol 2003; 121: 1117-1119.

CHAPTER 7 Proteom ics in uveal m elanom a. Short Report 119

Melanoma Res 2003; 13: 627-629.

CHAPTER 8 Sum m ary and discussion 125

Sam envatting

Curriculum Vitae

(4)

Referenties

GERELATEERDE DOCUMENTEN

Het onderzoek van dit proefschrift is gefinancierd door de Mozaiekbeurs (017.003.059) van De Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), Landelijke Stichting

Since we already know that therapeutic long peptide vaccination alone is not effective in a mouse melanoma model, we describe in Chapter 9 the effect of the additional use of

CD11b+ macrophages have been attributed a role in T cell regulation, and McKenna and Kapp 59 showed that they are also involved in immune regulation against intraocular tumors

Conclusions: Monosomy 3 in uveal melanoma is associated with the presence of an inflammatory phenotype, consisting of a high HLA Class I and II expression as well

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden. Downloaded

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden. Downloaded

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden. Downloaded

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden. Downloaded